-
1
-
-
27644549042
-
State of the art: IBD therapy and clinical trials in IBD
-
Isaacs K.L., Lewis J.D., Sandborn W.J., et al. State of the art: IBD therapy and clinical trials in IBD. Inflamm Bowel Dis 11 Suppl 1 (2005) S3-S12
-
(2005)
Inflamm Bowel Dis
, vol.11
, Issue.SUPPL. 1
-
-
Isaacs, K.L.1
Lewis, J.D.2
Sandborn, W.J.3
-
2
-
-
23044476655
-
Update in medical therapy of ulcerative colitis: newer concepts and therapies
-
Katz S. Update in medical therapy of ulcerative colitis: newer concepts and therapies. J Clin Gastroenterol 39 (2005) 557-569
-
(2005)
J Clin Gastroenterol
, vol.39
, pp. 557-569
-
-
Katz, S.1
-
3
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
-
Hanauer S.B., Feagan B.G., Lichtenstein G.R., et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 359 (2002) 1541-1549
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
-
4
-
-
0033529049
-
Infliximab for the treatment of fistulas in patients with Crohn's disease
-
Present D.H., Rutgeerts P., Targan S., et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340 (1999) 1398-1405
-
(1999)
N Engl J Med
, vol.340
, pp. 1398-1405
-
-
Present, D.H.1
Rutgeerts, P.2
Targan, S.3
-
5
-
-
10744221312
-
Infliximab maintenance therapy for fistulizing Crohn's disease
-
Sands B.E., Anderson F.H., Bernstein C.N., et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350 (2004) 876-885
-
(2004)
N Engl J Med
, vol.350
, pp. 876-885
-
-
Sands, B.E.1
Anderson, F.H.2
Bernstein, C.N.3
-
6
-
-
0030954732
-
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group
-
Targan S.R., Hanauer S.B., van Deventer S.J., et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337 (1997) 1029-1035
-
(1997)
N Engl J Med
, vol.337
, pp. 1029-1035
-
-
Targan, S.R.1
Hanauer, S.B.2
van Deventer, S.J.3
-
7
-
-
33750105599
-
Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis
-
Lawson M.M., Thomas A.G., and Akobeng A.K. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 3 (2006) CD005112
-
(2006)
Cochrane Database Syst Rev
, vol.3
-
-
Lawson, M.M.1
Thomas, A.G.2
Akobeng, A.K.3
-
8
-
-
28844473957
-
Infliximab for induction and maintenance therapy for ulcerative colitis
-
Rutgeerts P., Sandborn W.J., Feagan B.G., et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353 (2005) 2462-2476
-
(2005)
N Engl J Med
, vol.353
, pp. 2462-2476
-
-
Rutgeerts, P.1
Sandborn, W.J.2
Feagan, B.G.3
-
9
-
-
0347991877
-
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients
-
Colombel J.F., Loftus Jr. E.V., Tremaine W.J., et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 126 (2004) 19-31
-
(2004)
Gastroenterology
, vol.126
, pp. 19-31
-
-
Colombel, J.F.1
Loftus Jr., E.V.2
Tremaine, W.J.3
-
10
-
-
33646147141
-
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
-
Lichtenstein G.R., Feagan B.G., Cohen R.D., et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 4 (2006) 621-630
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 621-630
-
-
Lichtenstein, G.R.1
Feagan, B.G.2
Cohen, R.D.3
-
11
-
-
33644829107
-
Complications of biological therapy for inflammatory bowel diseases
-
Blonski W., and Lichtenstein G.R. Complications of biological therapy for inflammatory bowel diseases. Curr Opin Gastroenterol 22 (2006) 30-43
-
(2006)
Curr Opin Gastroenterol
, vol.22
, pp. 30-43
-
-
Blonski, W.1
Lichtenstein, G.R.2
-
12
-
-
0026761751
-
Colorectal cancer risk and mortality in patients with ulcerative colitis
-
Langholz E., Munkholm P., Davidsen M., and Binder V. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103 (1992) 1444-1451
-
(1992)
Gastroenterology
, vol.103
, pp. 1444-1451
-
-
Langholz, E.1
Munkholm, P.2
Davidsen, M.3
Binder, V.4
-
13
-
-
0028338424
-
Course of ulcerative colitis: analysis of changes in disease activity over years
-
Langholz E., Munkholm P., Davidsen M., and Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 107 (1994) 3-11
-
(1994)
Gastroenterology
, vol.107
, pp. 3-11
-
-
Langholz, E.1
Munkholm, P.2
Davidsen, M.3
Binder, V.4
-
14
-
-
4344602852
-
Guidelines for the management of inflammatory bowel disease in adults
-
Carter M.J., Lobo A.J., and Travis S.P. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 Suppl 5 (2004) V1-V16
-
(2004)
Gut
, vol.53
, Issue.SUPPL. 5
-
-
Carter, M.J.1
Lobo, A.J.2
Travis, S.P.3
-
15
-
-
0028142755
-
Surgery for ulcerative colitis in the era of the pouch: the St Mark's Hospital experience
-
Melville D.M., Ritchie J.K., Nicholls R.J., and Hawley P.R. Surgery for ulcerative colitis in the era of the pouch: the St Mark's Hospital experience. Gut 35 (1994) 1076-1080
-
(1994)
Gut
, vol.35
, pp. 1076-1080
-
-
Melville, D.M.1
Ritchie, J.K.2
Nicholls, R.J.3
Hawley, P.R.4
-
16
-
-
4644227644
-
The effect of ageing on function and quality of life in ileal pouch patients: a single cohort experience of 409 patients with chronic ulcerative colitis
-
Hahnloser D., Pemberton J.H., Wolff B.G., et al. The effect of ageing on function and quality of life in ileal pouch patients: a single cohort experience of 409 patients with chronic ulcerative colitis. Ann Surg 240 (2004) 615-621
-
(2004)
Ann Surg
, vol.240
, pp. 615-621
-
-
Hahnloser, D.1
Pemberton, J.H.2
Wolff, B.G.3
-
17
-
-
33645018005
-
Revolution and evolution: 30 years of ileoanal pouch surgery
-
Bach S.P., and Mortensen N.J. Revolution and evolution: 30 years of ileoanal pouch surgery. Inflamm Bowel Dis 12 (2006) 131-145
-
(2006)
Inflamm Bowel Dis
, vol.12
, pp. 131-145
-
-
Bach, S.P.1
Mortensen, N.J.2
-
18
-
-
0031754979
-
Incidence and subsequent impact of pelvic abscess after ileal pouch-anal anastomosis for chronic ulcerative colitis
-
Farouk R., Dozois R.R., Pemberton J.H., and Larson D. Incidence and subsequent impact of pelvic abscess after ileal pouch-anal anastomosis for chronic ulcerative colitis. Dis Colon Rectum 41 (1998) 1239-1243
-
(1998)
Dis Colon Rectum
, vol.41
, pp. 1239-1243
-
-
Farouk, R.1
Dozois, R.R.2
Pemberton, J.H.3
Larson, D.4
-
19
-
-
0029156462
-
Ileal pouch-anal anastomoses complications and function in 1005 patients
-
Fazio V.W., Ziv Y., Church J.M., et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg 222 (1995) 120-127
-
(1995)
Ann Surg
, vol.222
, pp. 120-127
-
-
Fazio, V.W.1
Ziv, Y.2
Church, J.M.3
-
20
-
-
2942668573
-
Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy
-
Colombel J.F., Loftus Jr. E.V., Tremaine W.J., et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99 (2004) 878-883
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 878-883
-
-
Colombel, J.F.1
Loftus Jr., E.V.2
Tremaine, W.J.3
-
21
-
-
33748111266
-
Safety, feasibility, and short-term outcomes of laparoscopic ileal-pouch-anal anastomosis: a single institutional case-matched experience
-
Larson D.W., Cima R.R., Dozois E.J., et al. Safety, feasibility, and short-term outcomes of laparoscopic ileal-pouch-anal anastomosis: a single institutional case-matched experience. Ann Surg 243 (2006) 667-670
-
(2006)
Ann Surg
, vol.243
, pp. 667-670
-
-
Larson, D.W.1
Cima, R.R.2
Dozois, E.J.3
-
22
-
-
33646696885
-
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials
-
Bongartz T., Sutton A.J., Sweeting M.J., et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295 (2006) 2275-2285
-
(2006)
JAMA
, vol.295
, pp. 2275-2285
-
-
Bongartz, T.1
Sutton, A.J.2
Sweeting, M.J.3
-
23
-
-
0036742119
-
Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications
-
Mahadevan U., Loftus Jr. E.V., Tremaine W.J., et al. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis 8 (2002) 311-316
-
(2002)
Inflamm Bowel Dis
, vol.8
, pp. 311-316
-
-
Mahadevan, U.1
Loftus Jr., E.V.2
Tremaine, W.J.3
-
24
-
-
0142011619
-
Long-term results of salvage surgery for septic complications after restorative proctocolectomy: does fecal diversion improve outcome?
-
Gorfine S.R., Fichera A., Harris M.T., and Bauer J.J. Long-term results of salvage surgery for septic complications after restorative proctocolectomy: does fecal diversion improve outcome?. Dis Colon Rectum 46 (2003) 1339-1344
-
(2003)
Dis Colon Rectum
, vol.46
, pp. 1339-1344
-
-
Gorfine, S.R.1
Fichera, A.2
Harris, M.T.3
Bauer, J.J.4
-
25
-
-
0036315375
-
Reconstructive surgery for failed ileal pouch-anal anastomosis: a viable surgical option with acceptable results
-
MacLean A.R., O'Connor B., Parkes R., et al. Reconstructive surgery for failed ileal pouch-anal anastomosis: a viable surgical option with acceptable results. Dis Colon Rectum 45 (2002) 880-886
-
(2002)
Dis Colon Rectum
, vol.45
, pp. 880-886
-
-
MacLean, A.R.1
O'Connor, B.2
Parkes, R.3
|